Aging is a ripe area for biotech startups, BioAge Labs co-founder and CEO Kristen Fortney observes. Also, she encourages biotech entrepreneurs to consider the advantages of taking a less-risky platform approach to therapeutics.
Aging is a ripe area for biotech startups, BioAge Labs co-founder and CEO Kristen Fortney observes. Also, she encourages biotech entrepreneurs to consider the advantages of taking a less-risky platform approach to therapeutics.